The Cardiovascular Grand Rounds are held on Thursdays from 12:00 to 1:00 PM.
Due to the COVID-19 Pandemic, and until further notice, allpresentations will take place via ZOOM.
Presentations, when available, will be uploaded. (Your ۲ݮƵ username and password are required toview the recording,click on the link belowtitle of the presentation.)
The CardiovascularGrand Roundsare an accredited group learning activity as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Date | Presenter | Details |
---|---|---|
December 17, 2020 | Michael Chetrit MD, FRCPC Assistant Professor of Medicine, ۲ݮƵuniversity, Cardiologist, ۲ݮƵ University HealthCentre Co-Director, ۲ݮƵ Amyloidosis Project |
“Unraveling” the Mystery of Cardiac Amyloidosis |
December 10, 2020 |
Allan D. Sniderman, MD, FRSC |
A New Paradigm for the Prevention of Cardiovascular Disease in Early and Midlife (and Later Life as well) |
December 3, 2020 |
Paul Poirier, MD, PhD, FRCPC, FCCS, FACC, FAHA |
What to do with the residual risk: choosing between the different options. |
November 26, 2020 | Julio Garcia, PhD, SNI-I, Junior FISMRM, SMIEEE Assistant Professor Libin Cardiovascular Institute - Stephenson Cardiac Imaging Centre Alberta Children’s Hospital Research Institute Department of Radiology and Cardiac Sciences University of Calgary - Cumming School of Medicine |
Cardiovascular 4D flow MRI: Current applications and need for longitudinal studies. |
November 12, 2020 |
Nicolo Piazza, MD, PhD, FRCPC, FESC, FACC |
Interventions on the tricuspid valve. Overview of the field |
November 5, 2020 | Laurent Macle MD, FRCP 䲹徱DZDzܱ-ÉٰDZDZDzٱ Professeur titulaire de Médecine, Université deMontréal Chef du service d’électrophysiologie, Institut deCardiologie de Montréal |
The 2020 Atrial Fibrillation Guidelines of theCanadian Cardiovascular Society Objectives: Know the latest CCS recommendations with regards to atrial fibrillation Understand the clinical applications of the latest CCS AF guidelines Select the appropriate antithrombotic treatment strategy in differentclinical settings |
October 29, 2020 |
Matthias G. Friedrich, MD |
Diagnosis and Treatment of Stable Coronary Artery Disease: Where Europeans and Americans Beg to Differ |
October 22, 2020 |
Murray Kornbluth, MD Martin Bernier, MD Haya Aziz, MD David Bracco, MD Christian Sirois, MD |
Cardiac Arrest in a Young Athlete: An “Unnerving” Solution |
October 15, 2020 |
Matthias G. Friedrich, MD Nadia Giannetti, MD Abhinav Sharma, MD PhD George Thanassoulis, MD MSc FRCP(C) Hao Yu Chen, MSc |
The Courtois Cardiovascular Signature Program - Paving the Way for Truly Personalized Cardiology at the MUHC |
October 8, 2020 |
Kevin Lachapelle, MD, FRCPS(C), FACS Judith Therrien MD, FRCPC Robert Doonan, MD Masaki Kodaira, MD Josephine Pressacco, MD, PhD |
Getting Personal: Genes and Aortopathy |
October 1, 2020 | Javed Butler, MD, MPH, MBA Patrick H. Lehan Chair in Cardiovascular Research Professor and Chairman, Department of Medicine Professor of Physiology University of Mississippi Medical Center |
Presentation and Discussion of EMPEROR-reduced trial results (Reported at ESC 2020) |
September 24, 2020 | Renato D. Lopes, MD, MHS, PhD Professor of Medicine Division of Cardiology Duke Clinical Research Institute Duke University Medical Center |
Antithrombotic Therapy for Patients with AF and PCI: Where do We Stand in 2020? |
September 10, 2020 | Magdi Sami, MD Cardiology Division MUHC |
Highlights from ECC2020 |
June 11, 2020 | Dr. Paul Dorian,MD, FRCPC Professor of Medicine, Division of Cardiology & Division of Clinical Pharmacology - University of Toronto Staff Scientist - Li Ka Shing Knowledge Institute |
Everything you would ever want to know about ATRIAL FIBRILLATION management during a pandemic |
June 4, 2020 | Magdi Sami, MD Cardiology Division MUHC |
Highlights from ACC 2020 - New Paradigms in the management of PAD, HF and AF |
May 28, 2020 |
George Thanassoulis, MD MSc FRCP(C) |
Guideline application in ACS Patients |
May 21, 2020 |
Matthias G. Friedrich MD ʰǴڱǰ, Adjunct ʰǴڱǰ, |
What happens to the heart in severe COVID-19 -important observations by cardiac imaging |
May 14, 2020 |
Yahya E. Alansari, MD Amr Telmesani, MD Ahmed AlTurki, MD |
Yahya E. Alansari, MD:Intra-Coronary Imaging Amr Telmesani, MD:The inclusion of peak tricuspid regurgitation jet velocity misclassifies diastolic function using the 2016 ASE/EACVI guidelines in pre-capillary pulmonary hypertension. Ahmed AlTurki, MD:Optimizing CRT Using A Simple Tool |